HAMPLATIN Trademark

Trademark Overview


On Monday, December 15, 2014, a trademark application was filed for HAMPLATIN with the United States Patent and Trademark Office. The USPTO has given the HAMPLATIN trademark a serial number of 86480624. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, October 13, 2023. This trademark is owned by MedOC Pharmaceutical Co., Ltd.. The HAMPLATIN trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Tonics of medicines, namely, medicinal tea; medicines for human purposes in the form of effervescent tablets, chewable tablet and chewing gum for use in preventing prostatitis, benign prostatic hyperplasia, urinary tract infection, gynecological inflammation, gastrointestinal disease; medicines for human purposes in the form of effervescent tablets, chewable tablet and chewing gum for use in blood sugar regulation, liver protection, and as antioxidants, anti-hyperlipidemia, anti-aging, antineoplastic and antiviral agents for medical use; Medicines for human purposes, namely, medicines for the treatment of gastrointestinal disease, skin disease, cardiovascular disease, gout, asthma, nasitis, prostatic cancer, leukemia, melanoma, brain glioma, colon cancer, cervical cancer, thyroid cancer, kidney cancer, stomach cancer and lung cancer, hepatitis B, hepatitis C, AIDS and influenza, prostatitis, benign prostatic hyperplasia and gynecological inflammation, diabetes, sleep disorder and rheum...

Technical research and development in the fields of vaccines, medicines, dietary supplements and food; Technical Project studies in the nature of scientific research; Quality testing for medicines, dietary supplements, food and medicine intermediate; Chemical analysis; Chemical engineering; Working on and evaluation of chemical syntheses; Chemical research; Bacteriological research; Biological research; Conducting clinical trials for others; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Industrial design
hamplatin

General Information


Serial Number86480624
Word MarkHAMPLATIN
Filing DateMonday, December 15, 2014
Status710 - CANCELLED - SECTION 8
Status DateFriday, October 13, 2023
Registration Number5171990
Registration DateTuesday, March 28, 2017
Mark Drawing5000 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, June 7, 2016

Trademark Statements


Description of MarkThe mark consists of the term "HAMPLATIN" in stylized font.
Goods and ServicesTonics of medicines, namely, medicinal tea; medicines for human purposes in the form of effervescent tablets, chewable tablet and chewing gum for use in preventing prostatitis, benign prostatic hyperplasia, urinary tract infection, gynecological inflammation, gastrointestinal disease; medicines for human purposes in the form of effervescent tablets, chewable tablet and chewing gum for use in blood sugar regulation, liver protection, and as antioxidants, anti-hyperlipidemia, anti-aging, antineoplastic and antiviral agents for medical use; Medicines for human purposes, namely, medicines for the treatment of gastrointestinal disease, skin disease, cardiovascular disease, gout, asthma, nasitis, prostatic cancer, leukemia, melanoma, brain glioma, colon cancer, cervical cancer, thyroid cancer, kidney cancer, stomach cancer and lung cancer, hepatitis B, hepatitis C, AIDS and influenza, prostatitis, benign prostatic hyperplasia and gynecological inflammation, diabetes, sleep disorder and rheumatoid arthritis; Medicinal drinks; Capsules sold empty for pharmaceuticals; Pharmaceutical preparations for the treatment of gastrointestinal disease, skin disease, cardiovascular disease, gout, asthma, nasitis, prostatic cancer, leukemia, melanoma, brain glioma, colon cancer, cervical cancer, thyroid cancer, kidney cancer, stomach cancer and lung cancer, hepatitis B, hepatitis C, AIDS and influenza, prostatitis, benign prostatic hyperplasia and gynecological inflammation, diabetes, sleep disorder and rheumatoid arthritis; Chemico-pharmaceutical preparations for tumor-suppression and antiviral treatment; Injectable syringes sold filled with vaccines, antivirals and tumor-suppression agents; Troches, namely, tablets for use in tumor-suppression, as antivirals and for the treatment of chronic gastrointestinal disease; Tinctura in the nature of medicinal herb extracts; Tincture of iodine; Tinctures in the nature of antiseptics for use in the treatment of traumatic injuries; Herbs for medicinal purposes
Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesTechnical research and development in the fields of vaccines, medicines, dietary supplements and food; Technical Project studies in the nature of scientific research; Quality testing for medicines, dietary supplements, food and medicine intermediate; Chemical analysis; Chemical engineering; Working on and evaluation of chemical syntheses; Chemical research; Bacteriological research; Biological research; Conducting clinical trials for others; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Industrial design

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, October 13, 2023
Primary Code005
First Use Anywhere DateTuesday, May 10, 2016
First Use In Commerce DateTuesday, May 10, 2016

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, October 13, 2023
Primary Code042
First Use Anywhere DateTuesday, May 10, 2016
First Use In Commerce DateTuesday, May 10, 2016

Trademark Owner History


Party NameMedOC Pharmaceutical Co., Ltd.
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressChangsha, Hunan
CN

Party NameMedOC Pharmaceutical Co., Ltd.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressChangsha, Hunan
CN

Party NameMedOC Pharmaceutical Co., Ltd.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressChangsha, Hunan
CN

Trademark Events


Event DateEvent Description
Friday, October 13, 2023CANCELLED SEC. 8 (6-YR)
Monday, March 28, 2022COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, March 28, 2017REGISTERED-PRINCIPAL REGISTER
Wednesday, February 22, 2017NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, February 21, 2017ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, February 15, 2017STATEMENT OF USE PROCESSING COMPLETE
Wednesday, January 25, 2017USE AMENDMENT FILED
Saturday, February 11, 2017CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, January 25, 2017TEAS STATEMENT OF USE RECEIVED
Tuesday, August 2, 2016NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 7, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 7, 2016PUBLISHED FOR OPPOSITION
Wednesday, May 18, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, April 29, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, April 26, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, April 25, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, April 25, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, October 27, 2015NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, October 27, 2015NON-FINAL ACTION E-MAILED
Tuesday, October 27, 2015NON-FINAL ACTION WRITTEN
Tuesday, September 29, 2015TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, September 28, 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, September 28, 2015TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, March 28, 2015NOTIFICATION OF NON-FINAL ACTION E-MAILED
Saturday, March 28, 2015NON-FINAL ACTION E-MAILED
Saturday, March 28, 2015NON-FINAL ACTION WRITTEN
Thursday, March 26, 2015ASSIGNED TO EXAMINER
Wednesday, March 4, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, December 19, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, December 18, 2014NEW APPLICATION ENTERED